Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06942104 · ClinicalTrials.gov registry record · Phase 1

Imaging of Solid Tumors Using 18F-TRX

A Phase 1 study of Solid Tumor and Metastatic Malignant Solid Neoplasm, sponsored by Rahul Aggarwal.

Recruiting
Registry status
Phase 1
Development phase
56
Enrollment target
1
Study location

NCT06942104 is a Phase 1 study of Solid Tumor and Metastatic Malignant Solid Neoplasm that is actively recruiting participants, run by Rahul Aggarwal. The registered enrollment target is 56 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06942104, a Phase 1 study of Solid Tumor and Metastatic Malignant Solid Neoplasm, is actively recruiting participants, sponsored by Rahul Aggarwal.

RECRUITING
Registry status
Phase 1
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissues, including tumors. Diagnostic procedures, such as 18F-TRX PET/CT or PET/MRI, may help detect tumors in patients with solid tumors

Conditions Studied

Solid Tumor Metastatic Malignant Solid Neoplasm Stage IVB Prostate Cancer AJCC v8 Castration-Resistant Prostate Carcinoma Stage IV Renal Cell Cancer AJCC v8 Glioma, Malignant Stage III Renal Cell Cancer AJCC v8 Metastatic Clear Cell Renal Cell Carcinoma Solid Carcinoma Locally Advanced Clear Cell Renal Cell Carcinoma

Interventions

  • PROCEDURE Blood Specimen Collection
  • PROCEDURE Tumor Biopsy
  • PROCEDURE Positron Emission Tomography (PET)/Computerized tomography (CT)
  • DRUG 18F-TRX

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2025-07-03
Est. Completion 2026-09-30
Phase Phase 1

Sponsor

Rahul Aggarwal

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06942104

The ClinicalTrials.gov registry entry for NCT06942104 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (75% lower). The listed sponsor is Rahul Aggarwal, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Solid Tumor appearing as the primary indexed condition, and to 4 interventions - of which Blood Specimen Collection is the first listed.

NCT06942104 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06942104 about?

NCT06942104 is a clinical study titled "Imaging of Solid Tumors Using 18F-TRX". This phase I trial tests the safety and effectiveness of 18F-TRX in detecting tumors (cancer) patients with solid tumors. 18F-TRX is an imaging tracer that is used to visualize tumors using a PET scan. It specifically targets and detects labile (unstable) iron levels within tissues, including tumors...

What is the current status of trial NCT06942104?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2025-07-03. Estimated completion is 2026-09-30.

What conditions does trial NCT06942104 study?

This clinical trial studies the following conditions: Solid Tumor, Metastatic Malignant Solid Neoplasm, Stage IVB Prostate Cancer AJCC v8, Castration-Resistant Prostate Carcinoma, Stage IV Renal Cell Cancer AJCC v8.

What interventions are being tested in trial NCT06942104?

The interventions under investigation include: Blood Specimen Collection (PROCEDURE), Tumor Biopsy (PROCEDURE), Positron Emission Tomography (PET)/Computerized tomography (CT) (PROCEDURE), 18F-TRX (DRUG).

Who is sponsoring clinical trial NCT06942104?

This trial is sponsored by Rahul Aggarwal, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06942104 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor

All registered trials for this condition

Metastatic Malignant Solid Neoplasm

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.